In a patient presenting with fever and sore throat, who has leukopenia, anemia, thrombocytopenia, elevated transaminases, hypertriglyceridemia, low fibrinogen, and markedly elevated ferritin, what is the most likely diagnosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hemophagocytic Syndrome due to EBV Infection (Answer: C)

The clinical presentation of pancytopenia (WBC 4,000, hemoglobin 8, platelets 70,000), elevated transaminases (SGOT 70, SGPT 85), hypertriglyceridemia (285 mg/dL), hypofibrinogenemia (100 mg/dL), and markedly elevated ferritin (1,100 ng/mL) in a febrile patient with sore throat is pathognomonic for hemophagocytic lymphohistiocytosis (HLH), most commonly triggered by EBV infection in this clinical context.

Diagnostic Reasoning

The constellation of laboratory findings meets multiple HLH-2004 diagnostic criteria 1:

  • Cytopenias in ≥2 cell lines: Present (anemia, thrombocytopenia, borderline leukopenia)
  • Hypertriglyceridemia: 285 mg/dL (≥265 mg/dL is diagnostic)
  • Hypofibrinogenemia: 100 mg/dL (≤150 mg/dL is diagnostic)
  • Hyperferritinemia: 1,100 ng/mL (≥500 ng/mL supports diagnosis)
  • Elevated transaminases: Consistent with hepatic involvement

The guideline emphasizes that the combination, extent, and progression of these clinical and laboratory abnormalities being unusual, unexpected, and otherwise unexplained is crucial for HLH diagnosis 1. This patient's multi-system involvement cannot be explained by simple pharyngitis.

Why Not the Other Options?

Streptococcal Pharyngotonsillitis (A) - Incorrect

  • Does not cause pancytopenia, hypofibrinogenemia, or hypertriglyceridemia
  • Would show leukocytosis, not leukopenia
  • Ferritin elevation would be modest, not marked

Diphtheria (B) - Incorrect

  • Causes local pharyngeal membrane and myocarditis/neuropathy
  • Does not produce this specific hematologic/metabolic profile
  • Extremely rare in vaccinated populations

Influenza (D) & RSV (E) - Incorrect

  • May cause mild cytopenias but not this severe multi-system picture
  • Do not cause hypofibrinogenemia or hypertriglyceridemia
  • Ferritin elevation would be minimal

Critical Context on Ferritin Interpretation

While hyperferritinemia is not specific for HLH 2, 3, the ferritin level of 1,100 ng/mL combined with the complete clinical picture strongly supports HLH. Research shows that ferritin >10,000 μg/L has higher specificity for HLH 4, 2, but lower levels do not exclude the diagnosis when other criteria are met 1.

The guideline explicitly states that ferritin elevation must be interpreted within the broader clinical context 5, and this patient's combination of findings—particularly the hypofibrinogenemia and hypertriglyceridemia—are highly specific for HLH rather than simple infection or inflammation.

EBV as the Trigger

EBV is one of the most common infectious triggers for secondary HLH, particularly in immunocompetent patients presenting with pharyngitis-like symptoms. The sore throat likely represents the initial EBV infection that triggered the hemophagocytic syndrome.

Common Pitfalls to Avoid

  • Do not dismiss HLH because ferritin is "only" 1,100: The diagnosis relies on multiple criteria, not ferritin alone 1
  • Do not wait for hemophagocytosis on bone marrow: This finding is neither sensitive nor specific and may be absent early 1
  • Do not attribute all findings to sepsis: The specific combination of hypofibrinogenemia + hypertriglyceridemia + cytopenias distinguishes HLH from sepsis

Immediate Next Steps

  • Calculate HScore (likely ≥169, indicating high probability of HLH)
  • Send EBV serology and PCR
  • Check soluble IL-2 receptor and NK cell activity
  • Consider bone marrow examination if diagnosis remains uncertain
  • Initiate HLH-directed therapy if clinical deterioration occurs before confirmatory testing

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.